Literature DB >> 1571411

Acquired factor X deficiency and disseminated intravascular coagulation in a case of metastasizing carcinoma of the stomach and its course under chemotherapy.

W Korte1, R Flury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1571411     DOI： 10.1007/bf01697403

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  9 in total

1.  Treatment of disseminated intravascular coagulation with low molecular weight heparin. Research Group of FR-860 on DIC in Japan.

Authors:  Y Oguma; N Sakuragawa; M Maki; H Hasegawa; M Nakagawa
Journal:  Semin Thromb Hemost       Date:  1990-10       Impact factor: 4.180

2.  Thrombosis and bleeding in cancer patients.

Authors:  F W Peuscher
Journal:  Neth J Med       Date:  1981       Impact factor: 1.422

3.  Cancer procoagulant in acute lymphoblastic leukemia.

Authors:  M G Alessio; A Falanga; R Consonni; R Bassan; B Minetti; M B Donati; T Barbui
Journal:  Eur J Haematol       Date:  1990-08       Impact factor: 2.997

4.  Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia.

Authors:  I Pabinger; P Bettelheim; R Dudczak; W Hinterberger; P A Kyrle; H Niessner; I Schwarzinger; W Speiser; K Lechner
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

5.  Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.

Authors:  M B Donati; A Falanga; R Consonni; M G Alessio; R Bassan; M Buelli; L Borin; L Catani; E Pogliani; L Gugliotta
Journal:  Thromb Haemost       Date:  1990-08-13       Impact factor: 5.249

6.  Cancer procoagulant in human tumor cells: evidence from melanoma patients.

Authors:  M B Donati; C Gambacorti-Passerini; B Casali; A Falanga; P Vannotti; G Fossati; N Semeraro; S G Gordon
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

7.  Factor X-activating activity in patients with colorectal carcinoma.

Authors:  R Dover; N L Goeting; I Taylor; O S Roath; J L Francis
Journal:  Br J Surg       Date:  1987-12       Impact factor: 6.939

8.  Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.

Authors:  A Falanga; A P Bolognese Dalessandro; B Casali; M C Roncaglioni; M B Donati
Journal:  Int J Cancer       Date:  1987-06-15       Impact factor: 7.396

9.  A factor X-activating cysteine protease from malignant tissue.

Authors:  S G Gordon; B A Cross
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.